the origins of ovarian cancer: from tp53 to stic lesions
Published 3 years ago • 520 plays • Length 3:51Download video MP4
Download video MP3
Similar videos
-
40:16
changing paradigms for the treatment of ovarian cancer
-
1:36
fibronectin and mutant p53 gene make for deadly duo in ovarian carcinomas
-
2:05
hrd testing in ovarian cancer
-
1:40
dr. landen discusses p53 mutations in ovarian cancer
-
1:12
where is ovarian cancer treatment headed?
-
3:03
barbara fiedler: conquering ovarian cancer
-
1:36
dr. tew evaluates bevacizumab treatment in ovarian cancer
-
0:49
p53 mutation and breast cancer - animated atlas of breast and gastric cancer
-
2:43
ask the trihealth expert: what should we know about ovarian cancer?
-
1:47
dr. bast on earlier detection of ovarian cancer
-
0:50
the ovarian cancer tumor storage center
-
1:05
dr. essel discusses long-term bevacizumab in ovarian cancer
-
1:01:31
research update in rarer ovarian cancers
-
2:50
secondary debulking in recurrent ovarian cancer
-
2:29
why roswell park for ovarian cancer?
-
6:57
bevacizumab in platinum-resistant ovarian cancer
-
1:23
dr. memarzadeh on p53 reactivation in ovarian cancer
-
5:58
mcg elm3b - ovarian cancer brca testing protocol
-
8:03
bevacizumab in platinum-sensitive ovarian cancer